Kura Oncology Inc. (KURA)
7.05
-0.09 (-1.26%)
At close: Mar 28, 2025, 3:59 PM
7.00
-0.71%
After-hours: Mar 28, 2025, 07:48 PM EDT
Kura Oncology Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | 53.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | 849K | 759K | 558K | 194K | n/a | 10K | 30K | 31K | 20K | 23.91K | 22.73K | 22.34K | 23.44K | 20.51K | 19.16K | n/a |
| Gross Profit | 53.88M | -849K | -759K | -558K | -194K | n/a | -10K | -30K | -31K | -20K | -23.91K | -22.73K | -22.34K | -23.44K | -20.51K | -19.16K | n/a |
| Operating Income | -193.19M | -165.8M | -140.62M | -131.82M | -92.09M | -67.48M | -62.88M | -36.08M | -28.37M | -23.86M | -11.8M | -22.34K | -23.44K | -20.51K | -41.02K | -38.32K | -33.62K |
| Interest Income | 22.85M | 14.72M | 4.25M | 1.21M | 2.8M | 4.67M | 3.17M | 751K | 499K | 128K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -171.97M | -152.63M | -135.84M | -130.47M | -89.63M | -63.14M | -60.45M | -35.43M | -27.56M | -22.63M | -11.01M | -27.32K | -27.04K | -22.39K | -22.39K | -20K | -33.62K |
| Net Income | -173.98M | -152.63M | -136.07M | -129.91M | -89.43M | -63.14M | -60.45M | -35.43M | -27.56M | -22.63M | -11.01M | -27.32K | -27.04K | -22.39K | -22.39K | -20K | -33.62K |
| Selling & General & Admin | 77.11M | 50.57M | 47.05M | 46.54M | 31.5M | 19.65M | 16.1M | 9.65M | 7.96M | 6.09M | 3.85M | 22.34K | 23.44K | 20.51K | 20.51K | 19.16K | n/a |
| Research & Development | 169.97M | 115.23M | 92.81M | 84.72M | 60.4M | 47.83M | 46.79M | 26.43M | 20.4M | 17.78M | 8.05M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | n/a | 4.03M | 792K | 2.27M | 4.34M | 2.44M | 643K | 807K | 1.24M | 2M | n/a | n/a | n/a | n/a | n/a | -33.62K |
| Operating Expenses | 247.08M | 165.8M | 139.87M | 131.26M | 91.9M | 67.48M | 62.88M | 36.08M | 28.37M | 23.86M | 10.9M | 22.34K | 23.44K | 20.51K | 20.51K | 19.16K | -33.62K |
| Interest Expense | 1.62M | 1.55M | 229K | 414K | 578K | 580K | 970K | 888K | 577K | 88K | 5.88K | 4.97K | 3.6K | 1.89K | 1.89K | 838.00 | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 247.08M | 165.8M | 139.87M | 131.26M | 91.9M | 67.48M | 62.88M | 36.08M | 28.37M | 23.86M | 10.9M | 22.34K | 23.44K | 20.51K | 41.02K | 38.32K | -33.62K |
| Income Tax | 2.02M | n/a | 229K | -558K | -194K | -10 | 3.41M | -30K | -31K | -20K | 268.88K | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 86.16M | 73.23M | 66.99M | 66.35M | 53.08M | 41.95M | 35.19M | 23.24M | 18.7M | 9.93M | 141K | 5M | 5M | 5M | 5M | 5M | n/a |
| Shares Outstanding (Diluted) | 86.16M | 73.23M | 66.99M | 66.35M | 53.08M | 41.95M | 35.19M | 23.24M | 18.7M | 9.93M | 141K | 5M | 5M | 5M | 5M | 5M | n/a |
| EPS (Basic) | -2.02 | -2.08 | -2.03 | -1.96 | -1.68 | -1.51 | -1.72 | -1.52 | -1.47 | -2.28 | -78.11 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | n/a |
| EPS (Diluted) | -2.02 | -2.08 | -2.03 | -1.96 | -1.68 | -1.51 | -1.72 | -1.52 | -1.47 | -2.28 | -78.11 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | n/a |
| EBITDA | -169.5M | -164.96M | -139.11M | -129.71M | -91.7M | -67.48M | -62.87M | -36.05M | -28.34M | -23.84M | -11.8M | -22.34K | -23.44K | -20.51K | -41.02K | -38.32K | -33.62K |
| Depreciation & Amortization | 23.7M | 849K | 759K | 558K | 194K | 10K | 10K | 30K | 31K | 20K | 3K | n/a | n/a | n/a | n/a | n/a | n/a |